ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOBLASTIC LEUKEMIA;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CAREER;
CHRONIC MYELOID LEUKEMIA;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
CONTINUOUS INFUSION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
HISTORY OF MEDICINE;
HUMAN;
LEUKEMIA;
MEDICAL PRACTICE;
MEDICAL RESEARCH;
REVIEW;
SINGLE DRUG DOSE;
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia
H. Kantarjian, D. Thomas, S. O'Brien Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia Cancer 101 2004 2788 2801
The usefulness of multiple pretreatment patient characteristic for prediction of response and survival in patients with adult acute leukemia
E.J. Freireich, E.A. Gehan, J.F. Speer The usefulness of multiple pretreatment patient characteristic for prediction of response and survival in patients with adult acute leukemia Adv Biosci 14 1973 131 144